MDxHealth (MDXH) Depreciation & Amortization (CF) (2021 - 2026)

MDxHealth has reported Depreciation & Amortization (CF) for 6 years, with the latest figure at $1.1 million in Q1 2026.

• Quarterly Depreciation & Amortization (CF) rose 21.62% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.8 million (up 77.34% YoY) and the FY2025 annual result came in at $4.0 million, up 28.14% from the prior year.
• Depreciation & Amortization (CF) declined to $1.1 million in Q1 2026 per MDXH's latest filing, from $2.8 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $2.8 million in Q3 2025 and troughed at $455000.0 in Q4 2023.
• A 5-year average of $1.2 million and a median of $863000.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2024 and 2025: Depreciation & Amortization (CF) slumped 61.99% in 2024, then surged 244.46% in 2025.
• Over 5 years, Depreciation & Amortization (CF) stood at $789000.0 in 2022, then sank by 42.33% to $455000.0 in 2023, then surged by 89.67% to $863000.0 in 2024, then surged by 227.69% to $2.8 million in 2025, then tumbled by 60.22% to $1.1 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $1.1 million, $2.8 million, and $1.9 million for Q1 2026, Q3 2025, and Q2 2025 respectively.